Avra Laboratories Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.00 Cr
- Company Age 29 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 123.72 Cr
- Revenue Growth 20.96%
- Profit Growth 34.87%
- Ebitda 60.38%
- Net Worth -18.05%
- Total Assets -4.91%
About Avra Laboratories
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24230MH1995PTC403253
- Company No.
021115
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 1995
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Avra Laboratories?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Venkatanaga Raju ![]() | Director | 13-Apr-2022 | Current |
Atin Jain ![]() | Director | 13-Apr-2022 | Current |
Jayant Manmadkar ![]() | Director | 13-Apr-2022 | Current |
Financial Performance of Avra Laboratories.
Avra Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.96% increase. The company also saw a substantial improvement in profitability, with a 34.87% increase in profit. The company's net worth observed a substantial decline by a decrease of 18.05%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Avra Laboratories?
In 2023, Avra Laboratories had a promoter holding of 99.98% and a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹0
₹123.72 Cr
Charges Breakdown by Lending Institutions
- Others : 78.33 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 21.00 Cr
- State Bank Of India : 16.20 Cr
- Technology Development Board : 4.75 Cr
- Ttechnology Development Board : 2.00 Cr
- Others : 1.44 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
29 Nov 2014 | The Hongkong And Shanghai Banking Corporation Limited | ₹10.00 Cr | Satisfied |
17 Nov 2014 | The Hongkong And Shanghai Banking Corporation Limited | ₹11.00 Cr | Satisfied |
22 Mar 2013 | Others | ₹78.33 Cr | Satisfied |
24 Jan 2006 | Technology Development Board | ₹4.75 Cr | Satisfied |
05 Dec 2002 | State Bank Of India | ₹13.35 Cr | Satisfied |
How Many Employees Work at Avra Laboratories?
Avra Laboratories has a workforce of 371 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Avra Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Avra Laboratories's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.